Results 31 to 40 of about 718 (153)

Juvenile Neuronal Ceroid Lipofuscinosis (JNCL) and the Eye [PDF]

open access: yesSurvey of Ophthalmology, 2009
Juvenile neuronal ceroid lipofuscinoses, or Batten disease, is the most common type of NCL in the United States and Europe. This devastating disorder presents with vision failure and progresses to include seizures, motor dysfunction, and dementia. Death usually occurs in the third decade, but some patients die before age twenty. Though the mechanism of
Sara, Bozorg   +3 more
openaire   +2 more sources

Advances in therapies for neurological lysosomal storage disorders

open access: yesJournal of Inherited Metabolic Disease, Volume 46, Issue 5, Page 874-905, September 2023., 2023
Abstract Lysosomal Storage Disorders (LSDs) are a diverse group of inherited, monogenic diseases caused by functional defects in specific lysosomal proteins. The lysosome is a cellular organelle that plays a critical role in catabolism of waste products and recycling of macromolecules in the body.
S. Ellison, H. Parker, B. Bigger
wiley   +1 more source

Imaging data on characterization of retinal autofluorescent lesions in a mouse model of juvenile neuronal ceroid lipofuscinosis (CLN3 disease). [PDF]

open access: yesData Brief, 2020
Juvenile neuronal ceroid lipofuscinosis (JNCL, aka. juvenile Batten disease or CLN3 disease), a lethal pediatric neurodegenerative disease without cure, often presents with vision impairment and characteristic ophthalmoscopic features including focal ...
Wang QJ, Jung KS, Mohan K, Kleinman ME.
europepmc   +2 more sources

Parkinsonism in Genetic Neurodevelopmental Disorders: A Systematic Review

open access: yesMovement Disorders Clinical Practice, Volume 10, Issue 1, Page 17-31, January 2023., 2023
Abstract Background With advances in clinical genetic testing, associations between genetic neurodevelopmental disorders and parkinsonism are increasingly recognized. In this review, we aimed to provide a comprehensive overview of reports on parkinsonism in genetic neurodevelopmental disorders and summarize findings related to genetic diagnosis ...
Emma N.M.M. von Scheibler   +7 more
wiley   +1 more source

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases

open access: yesCNS Neuroscience &Therapeutics, Volume 29, Issue 1, Page 37-59, January 2023., 2023
Abnormal activation of TFEB leads to dysfunction of ALP pathway in neurodegenerative diseases. Growing evidence shows that overexpression of TFEB or TFEB‐targeted small molecules promotes the degradation of abnormal aggregation proteins and significantly improves the abnormal behavioral characteristics of animal models. This review mainly summarize the
Fengjuan Jiao, Bojie Zhou, Lingyan Meng
wiley   +1 more source

Gene correction of the CLN3 c.175G>A variant in patient‐derived induced pluripotent stem cells prevents pathological changes in retinal organoids

open access: yesMolecular Genetics &Genomic Medicine, Volume 9, Issue 3, March 2021., 2021
In this paper, we examined the phenotype of retinal organoids derived from a patient with non‐syndromic CLN3 disease. We showed that accumulation of subunit C of mitochondrial ATPase occurs in patient retinal cells and cardiomyocytes, and could be prevented by gene correction.
Xiao Zhang   +10 more
wiley   +1 more source

The Batten disease gene Cln3 is required for the activation of intestinal stem cell during regeneration via JAK/STAT signaling in Drosophila. [PDF]

open access: yesFront Cell Dev Biol
CLN3 mutation causes Juvenile neuronal ceroid lipofuscinosis (JNCL, also known as Batten disease), an early onset neurodegenerative disorder. Patients who suffer from Batten disease often die at an early age.
Yu Z   +5 more
europepmc   +2 more sources

Reversible synaptic deficits in early-stage batten disease. [PDF]

open access: yesJ Transl Med
Background Juvenile neuronal ceroid lipofuscinosis (JNCL, Batten Disease) is a childhood-onset, neurodegenerative, lysosomal storage disorder caused by mutations in the lysosomal gene CLN3. Progressive cognitive decline is characteristic clinical feature,
Wani MA   +4 more
europepmc   +2 more sources

A timeline of symptom onset and disease progression in CLN3 disease. [PDF]

open access: yesOrphanet J Rare Dis
Background CLN3 disease, or Juvenile Neuronal Ceroid Lipofuscinosis (JNCL), is a rare, genetic neurodegenerative condition, typically manifesting in the first decade of life and progressing in severity, with death typically occurring in early adulthood ...
Whiteman IT   +11 more
europepmc   +2 more sources

Identification of Pathogenic Copy Number Variants in Mexican Patients With Inherited Retinal Dystrophies Applying an Exome Sequencing Data-Based Read-Depth Approach. [PDF]

open access: yesMol Genet Genomic Med
Exome sequencing (ES) data‐based read‐depth bioinformatic analysis was performed in 30 patients with retinal dystrophy who had a negative ES result. Five cases were solved by the identification of pathogenic copy number variations (CNVs). Bioinformatic analysis focused on CNV detection should be incorporated in samples with an inconclusive molecular ...
Fabian-Morales GE   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy